The COVID-19 Response Inquiry Submissions (Cancer AEFI)

A content analysis of the published submissions to Australia's COVID-19 Response Inquiry focusing on keywords relating to malignant cancers.

May 05, 2024

A note to my subscribers, this is a long article consisting of screenshots of submissions to the COVID-19 Response Inquiry. It will most definitely be truncated by most email providers. Please read it via Substack.

Australia’s “COVID-19 Response Inquiry” recently published the submissions at its webpage.

We have made these available for you to download as a compressed .zip file here.

Methodology

As we did in the first of these series of articles, we performed a content analysis on the 1,814 submissions published and downloadable as a .pdf attachment from the COVID-19 Response Inquiry's webpage. On this occasion, our analysis focused on identifying the prevalence of specific keywords associated with all malignant cancers, including:

Cancer
Tumour
Lymphoma

As we also did in our first of these series of articles, we only included those submissions where the authors describe their own personal experience, or that of a family member, friend, colleague or acquaintance who has suffered from cancer temporally associated with their COVID-19 “vaccination”.

It is plausible that many other cases were missed due to the peculiarly inconsistent redactions applied by the COVID-19 Response Inquiry team. For example, in Submission # 1782, it appears that the author of the submission has, for no obvious reason, had the disclosure of a diagnosis redacted even though a sentence earlier it was not redacted.

We estimate, therefore, that our methodology in Parts 1 and 2 of this article will have missed some (possibly many) submissions that had AEFIs redacted for mysterious reasons.

Results

In total, 135 of the publicly available submissions mentioned the word “cancer”, and 19 of these detail the accounts of individuals whose cancers worsened, emerged unexpectedly, or reactivated despite being in remission.

We present the following submissions, without further discussion or comment.